Company / Book Value per Share
NOVAVAX INC Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
-$0.796
FY2025
5-year range
-$8.332 / $8.27
FY2021-FY2025
Trend
+82.2%
vs FY2024
Sector context
#198 of 209
Health Care
What the data says
Among 209 Health Care companies, NOVAVAX INC is in the bottom 5% for book value per share. Book Value per Share has fluctuated over the past 10 years, ranging from -$8.332 in FY2023 to $19.387 in FY2020.
Based on SEC 10-K filings.
-$0.796 in FY2025.
Improved from -$8.332 to -$0.796 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 209This company -$0.796 Sector average $215.686
▼
-100.4% below sector average
Key checks
Key Insights
- In FY2025, book value per share increased 82.2% year-over-year.
- Ranks #198 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2020.
- Lowest book value per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.796 | +82.2% |
| FY2024 | -$4.472 | +46.3% |
| FY2023 | -$8.332 | -200.8% |
| FY2022 | $8.27 | +266.9% |
| FY2021 | -$4.956 | -125.6% |
| FY2020 | $19.387 | +466.3% |
| FY2019 | -$5.292 | -30744.7% |
| FY2018 | -$0.017 | -101.6% |
| FY2017 | $1.079 | +26.9% |
| FY2016 | $0.851 | -0.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026